Virosomes

Semi-synthetic complex derived from nucleic-acid free viral particles. They are essentially reconstituted viral coats, where the infectious nucleocapsid is replaced by a compound of choice. Virosomes retain their fusogenic activity and thus deliver the incorporated compound (antigens, drugs, genes) inside the target cell. They can be used for vaccines (VACCINES, VIROSOME), drug delivery, or gene transfer.

Also Known As:

Virosome

Biomedical and Dental Materials
- Artificial Membranes: 99
  - Virosomes: 194
Pharmaceutical Preparations
- Dosage Forms: 1139
  - Drug Carriers: 2375
    - Virosomes: 194
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Artificial Membranes: 99
      - Virosomes: 194
  - Biomimetic Materials
    - Artificial Membranes: 99
      - Virosomes: 194

K Colberg Selected Research

K Colberg Research Topics

Disease

Drug/Important Bio-Agent (IBA)